Skip to main content
. 2017 Dec 20;8:1862. doi: 10.3389/fimmu.2017.01862

Table 2.

Performance indicators and levels of agreement for the overall assay (OVA)’s results.a

Criterion Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%) McNemar’s test p-value Cohen’s kappa
Pre-immunization titer (mg/L)
≤26b 64.3 (48.0–78.4) 75.0 (50.9–91.3) 84.4 (67.2–94.7) 50.0 (31.3–68.7) 0.154 0,31 (0.08–0.53)
Post-immunization titer (mg/L)
≤110 57.8 (38.7–70.2) 100.0 (83.2–100.0) 100.0 (85.2–100.0) 51.3 (34.8–67.6) 0.761 0.53 (0.39–0.66)
≤230b 88.1 (74.4–96.0) 80.0 (56.3–94.3) 90.2 (76.9–97.3) 76.2 (52.8–91.8) 0.008 0.52 (0.29–0.75)
Post-immunization increase in titer (mg/L)
≤139b 81.0 (65.9–91.4) 90 (68.3–98.8) 94.4 (81.3–99.3) 69.2 (48.2–85.7) 0.049 0.57 (0.36–0.79)
Post-/pre-ratio
≤4.9b 66.7 (50.5–80.4) 80 (56.3–94.3) 87.5 (71.0–96.5) 53.3 (34.3–71.7) 0.126 0.39 (0.17–0.60)

aComparatively to the vaccine response status as assessed by the serotype-specific assay and using the American Academy of Asthma, Allergy and Immunology criteria (2).

bSelected using the Youden index. The selected threshold’s performances are highlighted in bold font.

All statistics are presented with the corresponding (95% confidence interval).